Basic Information
Xencor Provides Protein Engineering Technology Platform for the Biotechnology Industry, Developing Superior Monoclonal Antibody Therapies for the Treatment of Autoimmune Diseases, Asthma, Allergic Diseases, and Cancer. Xencor has also Discovered Biologics that Improve the Performance of Older Antibody Drugs, Known as "Bio-better Drugs," Which Can Benefit Patients, Reduce Compliance Burdens, and Help Lower Costs.
Xencor, Inc.
California,United States of America
51~100 people
January 01, 1997
info@xencor.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios